Nanwei W. Tong

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Serum Bone-, Muscle- and Fat- Derived Factors Sclerostin, Irisin and Leptin Show Different Correlations With Body Composition and Bone Mineral Density in Chinese Men With Obesity: A Cross-Sectional Study.

Serum Bone-, Muscle- and Fat- Derived Factors Sclerostin, Irisin and Leptin Show Different Correlations With Body Composition and Bone Mineral Density in Chinese Men With Obesity: A Cross-Sectional Study.

Journal: Diabetes/metabolism research and reviews

Published: May 09, 2026

The primary preventive effect of sodium-glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis.

The primary preventive effect of sodium-glucose cotransporter inhibitors on chronic kidney disease in patients with type 2 diabetes: a systematic review and meta-analysis.

Journal: Frontiers in endocrinology

Published: December 05, 2025

Empty Sella and Cushing's Disease: Lessons Learned from a Diagnostically Challenging Case.

Empty Sella and Cushing's Disease: Lessons Learned from a Diagnostically Challenging Case.

Journal: Neuro endocrinology letters

Published: September 21, 2025

Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.

Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.

Journal: Diabetes, obesity & metabolism

Published: September 16, 2025

The Effect of Konjac Glucomannan on Blood Glucose and Insulin Levels in Obese Patients With Prediabetes

The Effect of Konjac Glucomannan on Blood Glucose and Insulin Levels in Obese Patients With Prediabetes

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

Published: July 14, 2025

A proteome-wide association study reveals novel plasma proteins as potential therapeutic targets for metabolic dysfunction-associated steatotic liver disease.

A proteome-wide association study reveals novel plasma proteins as potential therapeutic targets for metabolic dysfunction-associated steatotic liver disease.

Journal: Frontiers in endocrinology

Published: July 12, 2025

Gut microbiota: a potential therapeutic target for hyperuricemia and gout.

Gut microbiota: a potential therapeutic target for hyperuricemia and gout.

Journal: Bioscience of microbiota, food and health

Published: June 20, 2025

Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis.

Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis.

Journal: Kidney diseases (Basel, Switzerland)

Published: June 04, 2025

Comparative effect of high intensity interval training and moderate intensity continuous training on metabolic improvements and regulation of Cidea and Cidec in obese C57BL/6 mice.

Comparative effect of high intensity interval training and moderate intensity continuous training on metabolic improvements and regulation of Cidea and Cidec in obese C57BL/6 mice.

Journal: PloS one

Published: January 12, 2025

Association between fetal sex and metabolic syndrome in women aged 40 years and older: the REACTION study.

Association between fetal sex and metabolic syndrome in women aged 40 years and older: the REACTION study.

Journal: PeerJ

Published: December 16, 2024

Effects of maternal levothyroxine supplementation during pregnancy on miscarriage and preterm delivery.

Effects of maternal levothyroxine supplementation during pregnancy on miscarriage and preterm delivery.

Journal: Chinese medical journal

Published: December 15, 2024

Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China).

Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China).

Journal: Advances in therapy

Published: November 24, 2024

Showing 1-12 of 136

Last Updated: 09/26/2026